HK1042231A1 - Dry powder active agent pulmonary delivery - Google Patents
Dry powder active agent pulmonary deliveryInfo
- Publication number
- HK1042231A1 HK1042231A1 HK02101738.3A HK02101738A HK1042231A1 HK 1042231 A1 HK1042231 A1 HK 1042231A1 HK 02101738 A HK02101738 A HK 02101738A HK 1042231 A1 HK1042231 A1 HK 1042231A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- active agent
- dry powder
- pulmonary delivery
- powder active
- agent pulmonary
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Otolaryngology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10016398P | 1998-09-14 | 1998-09-14 | |
PCT/US1999/021109 WO2000015262A1 (en) | 1998-09-14 | 1999-09-13 | Dry powder active agent pulmonary delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1042231A1 true HK1042231A1 (en) | 2002-08-09 |
Family
ID=22278404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02101738.3A HK1042231A1 (en) | 1998-09-14 | 2002-03-06 | Dry powder active agent pulmonary delivery |
Country Status (44)
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198593C (en) | 1999-06-09 | 2005-04-27 | 罗伯特·E·希弗斯 | Supercritical fluid-assisted nebulization and bubble drying |
US6475468B2 (en) * | 2001-02-15 | 2002-11-05 | Aeropharm Technology Incorporated | Modulated release particles for aerosol delivery |
EP1392262A1 (en) * | 2001-05-24 | 2004-03-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
CN1671643B (en) | 2002-02-25 | 2013-05-29 | 扩散药品有限公司 | Bipolar trans carotenoid salts and their uses |
WO2004004798A2 (en) * | 2002-07-03 | 2004-01-15 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
MXPA05006802A (en) * | 2002-12-19 | 2005-09-08 | Pharmacia Corp | Non-hygroscopic formulation comprising a hydroscopic drug. |
DE10338403A1 (en) * | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant |
GB0327723D0 (en) * | 2003-09-15 | 2003-12-31 | Vectura Ltd | Pharmaceutical compositions |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
MXPA06012240A (en) | 2004-04-23 | 2007-01-31 | Cydex Inc | Dpi formulation containing sulfoalkyl ether cyclodextrin. |
EP2540696B1 (en) * | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans carotenoids, formulation and uses |
KR20070110418A (en) * | 2005-03-09 | 2007-11-16 | 오노 야꾸힝 고교 가부시키가이샤 | Particle and preparation containing the particle |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
MX348982B (en) | 2005-10-26 | 2017-07-06 | Cydex Pharmaceuticals Inc | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof. |
US20100269819A1 (en) * | 2006-08-14 | 2010-10-28 | Sievers Robert E | Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions |
US20100093875A1 (en) * | 2006-10-25 | 2010-04-15 | Dainippon Sumitomo Pharma Co., Ltd. | Granular preparation prevented from caking |
EP1925295A1 (en) * | 2006-11-22 | 2008-05-28 | Boehringer Ingelheim Pharma GmbH & Co. KG | Stable powder formulation containing a new antichinolinergic agent |
EP3483140A1 (en) | 2007-04-13 | 2019-05-15 | Diffusion Pharmaceuticals LLC | Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease |
CN101878040A (en) | 2007-10-31 | 2010-11-03 | 扩散药品有限公司 | A new class of therapeutics that enhance small molecule diffusion |
US9610343B2 (en) * | 2009-05-20 | 2017-04-04 | Aeras Global Tb Vaccine Foundation | Stable, spray dryed, immunogenic, viral compositions |
CN108464976A (en) | 2009-06-22 | 2018-08-31 | 扩散药品有限公司 | Diffusion promotes compound and its independent or application together with Thrombolytic Drugs |
US8974822B2 (en) | 2010-06-02 | 2015-03-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
JP6349304B2 (en) | 2012-05-03 | 2018-06-27 | ヤンセン・サイエンシズ・アイルランド・ユーシー | Polyinosine-polycytidylic acid (poly (I: C)) formulation for the treatment of upper respiratory tract infections |
BR112015010601B1 (en) * | 2012-11-09 | 2022-07-19 | Civitas Therapeutics, Inc. | PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOSITION |
WO2015042352A1 (en) * | 2013-09-20 | 2015-03-26 | Virginia Commonwealth University | Delivery of particles using hygroscopic excipients |
EP3212212B1 (en) | 2014-10-31 | 2020-09-23 | Monash University | Powder formulation |
KR102489034B1 (en) | 2016-03-24 | 2023-01-13 | 디퓨젼 파마슈티컬즈 엘엘씨 | Use of Bipolar Trans Carotenoids with Chemotherapy and Radiation Therapy to Treat Cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3155573A (en) * | 1958-05-06 | 1964-11-03 | Benger Lab Ltd | Inhalant composition and method of making same |
WO1993025198A1 (en) * | 1992-06-12 | 1993-12-23 | Teijin Limited | Ultrafine powder for inhalation and production thereof |
US6524557B1 (en) * | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
WO1998031346A1 (en) * | 1997-01-16 | 1998-07-23 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US6086376A (en) * | 1998-01-30 | 2000-07-11 | Rtp Pharma Inc. | Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant |
-
1999
- 1999-09-09 MA MA25762A patent/MA25590A1/en unknown
- 1999-09-13 EE EEP200100151A patent/EE200100151A/en unknown
- 1999-09-13 YU YU24201A patent/YU24201A/en unknown
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 AR ARP990104587A patent/AR022090A1/en unknown
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/en unknown
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 CN CN99810871A patent/CN1317977A/en active Pending
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/en unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/en unknown
- 1999-09-13 PL PL99346768A patent/PL195574B1/en not_active IP Right Cessation
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/en not_active Application Discontinuation
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/en active
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/en not_active Withdrawn
- 1999-09-13 TW TW088115876A patent/TWI226248B/en not_active IP Right Cessation
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/en unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 IL IL14156299A patent/IL141562A0/en not_active IP Right Cessation
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/en unknown
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/en not_active IP Right Cessation
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 UA UA2001031707A patent/UA76085C2/en unknown
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/en not_active Application Discontinuation
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Application Discontinuation
- 1999-09-13 ID IDW20010582A patent/ID28845A/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/en active IP Right Revival
- 1999-09-14 GT GT199900156A patent/GT199900156A/en unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/en unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/en unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/en unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/en not_active Application Discontinuation
- 1999-10-31 SA SA99200718A patent/SA99200718B1/en unknown
-
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/en unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/en not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/en not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/en unknown
- 2001-03-14 HR HR20010189A patent/HRP20010189A2/en not_active Application Discontinuation
- 2001-04-10 BG BG105430A patent/BG105430A/en unknown
-
2002
- 2002-03-06 HK HK02101738.3A patent/HK1042231A1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL346768A1 (en) | Dry powder active agent pulmonary delivery | |
EP0927025A4 (en) | Liposome encapsulated active agent dry powder composition | |
PL343276A1 (en) | Aerosolized active agent delivery | |
EP1307256A4 (en) | Dry powder inhaler | |
SI1294421T1 (en) | Dry Powder Inhaler | |
IL128030A0 (en) | Dry powder inhaler | |
PL360118A1 (en) | Continuous dry powder inhaler | |
IL137472A (en) | Microparticle inhalation formulations | |
IL149362A0 (en) | Aerosol composition comprising formoterol | |
DE60035911D1 (en) | dry powder inhaler | |
HUP0104483A3 (en) | Fungicidal active substance combinations and use thereof | |
HUT74899A (en) | Dry powder inhaler | |
HUP0104579A3 (en) | Glp-1 analogues, pharmaceutical compositions comprising thereof and their use | |
EP1487417A4 (en) | Dry powder medicament formulations | |
HK1064313A1 (en) | Powder formulation disintegrating system and dry powder inhalers | |
PL341820A1 (en) | Coating composition in the form of dry powder | |
IL147390A0 (en) | Dry powder compositions | |
HUP0203611A3 (en) | 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments | |
GB0003935D0 (en) | Formulation for dry powder inhaler | |
GB9719093D0 (en) | Improvements to dry powder inhalers | |
AU1752601A (en) | Dry powder inhaler | |
CZ20021359A3 (en) | Preparation for fighting dry rots | |
HUP0105425A3 (en) | Suspo-emulsion formulation | |
GB0028828D0 (en) | Improved pesticide formulation | |
AU129749S (en) | Dry powder inhaler |